Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 8월 23

Genmab AS

GMABNASDAQ
Trade with Public
Trade with Public
$33.45
0.040.12%
가까이에: Aug 21, 5:00 PM EST
$33.70
0.250.75%
시간외: Aug 21, 6:17 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

Genmab Financials

Genmab (GMAB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Genmab Raises FY2026 Sales Guidance from $4.065B-$4.395B to $4.325B-$4.525B vs $4.355B Est

Genmab (NASDAQ:GMAB) raises FY2026 sales outlook from $4.065 billion-$4.395 billion to $4.325 billion-$4.525 billion vs $4.355 billion estimate.
Benzinga Newsdesk

PRO
Genmab Affirms FY2026 Sales Guidance of $4.065B-$4.395B vs $4.300B Est

Genmab (NASDAQ:GMAB) affirms FY2026 sales outlook from $4.065 billion-$4.395 billion to $4.065 billion-$4.395 billion vs $4.300 billion estimate.
Benzinga Newsdesk

PRO
Genmab Q1 EPADS $0.083 Misses $0.17 Estimate, Sales $896.000M Beat $890.400M Estimate

Benzinga Newsdesk

PRO
Genmab Sees FY2026 Sales $4.065B-$4.395B vs $4.214B Est

Genmab (NASDAQ:GMAB) sees FY2026 sales of $4.065 billion-$4.395 billion vs $4.214 billion analyst estimate.
Benzinga Newsdesk

PRO
Genmab Q4 EPS $0.05 Misses $0.44 Estimate, Sales $1.058B Miss $4.401B Estimate

Genmab (NASDAQ:GMAB) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.44 by 88.64 percent. This is a 94.12 percent decrease over earnings of $0.85 per share from the same
Benzinga Newsdesk

Genmab: Q4 Earnings Insights

Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved